The FDA restricted the import of certain banana ketchup and other Filipino condiments because some of their ingredients exceed permissible levels. The ingredients of concern include potassium ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...

The FDA requires labeling changes to the prescribing information for Pfizer and GSK RSV vaccines to include warnings about the risk for GBS.

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

The FDA has approved three RSV vaccines for preventing LRTD: Arexvy for those aged 50 and older, and Abrysvo and mResvia for those aged 60 and older. Abrysvo is also approved for individuals aged 18 ...

These treatments can include: The Food and Drug Administration (FDA) has approved three vaccines to prevent lower respiratory tract disease (LRTD) caused by RSV. Arexvy is approved for individuals ...